Susan C. Thornton, PhD.
About Susan C. Thornton, PhD.
Professional Background of Susan Thornton
Susan Thornton is currently the Chief Executive Officer. She has extensive experience in international business development, deal sourcing, due diligence, integration, and restructuring. Throughout her career, she has achieved sustained financial growth by developing new business strategies and improving operating efficiencies. Her background includes pivotal roles in influential companies where she led significant projects and transformations.
Susan Thornton's Education and Expertise
Susan Thornton holds a PhD in Molecular Biology from the University of Pennsylvania. She also earned an M.S. in Microbiology and a B.S. in Psychology from Pennsylvania State University. Her academic background in molecular biology, microbiology, and psychology has provided her with a diverse skill set that has been instrumental in her various leadership roles within the healthcare and pharmaceutical industries.
CEO Susan Thornton's Previous Roles
Before her current role as CEO, Susan Thornton served as an Executive in Residence with MDS Capital, a healthcare venture capital firm. She was also the President of Global Clinical Research and Central Labs for MDS, where she guided the organization through significant changes following the acquisition of six regional companies. Additionally, she worked as Director of Worldwide Business Development for GlaxoSmithKline, where she led teams in the negotiation and acquisition of new products.
Susan Thornton's Experience in Business Development
Susan Thornton has a substantial background in international business development. Her professional career includes deal sourcing and due diligence, where she has been responsible for identifying and evaluating potential acquisitions and partnerships. She has considerable experience in integration and restructuring, helping companies adapt and thrive post-acquisition or during periods of significant transition.